Menu Search
Equities

Stoke Therapeutics Inc

0GT:DUS

Stoke Therapeutics Inc

Actions
  • Price (EUR)12.90
  • Today's Change-0.90 / -6.52%
  • Shares traded50.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 15:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Stoke Therapeutics Inc increased its cash reserves by 68.25%, or 77.89m. Cash Flow from Investing totalled 105.95m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 81.07m for operations while cash generated from financing totalled 53.01m.
Cash flow per share-2.12
Price/Cash flow per share--
Book value per share4.64
Tangible book value per share4.64
More ▼

Balance sheet in USDView more

Stoke Therapeutics Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio6.67
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.